1-O-octadecyl-2-O-methyl-glycerophosphocholine inhibits the transduction of growth signals via the MAPK cascade in cultured MCF-7 cells

Journal of Clinical Investigation

Volumn 98, Issue 4, 1996, Pages 937-944

  Zhou, Xi ^a   Lu, Xiaoli ^a   Richard, Christina ^a   Xiong, Wei ^a   Litchfield, David W ^a,b   Bittman, Robert ^c   Arthur, Gilbert ^a,d  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c CITY UNIVERSITY OF NEW YORK   (United States)

^d UNIVERSITY OF MANITOBA   (Canada)

Author keywords

antineoplastic agents; cell division; phospholipid ethers; protein kinases; signal transduction

Indexed keywords

EDELFOSINE; EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME REGULATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; INHIBITION KINETICS; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

EID: 0029787879     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118877     Document Type: Article

References (38)

1. Berdel, W.E. 1991. Membrane-interactive lipids as experimental anticancer drugs. Br. J. Cancer. 64:208-211.
2. Lohmeyer, M., and R. Bittman. 1994. Antitumor ether lipids and alkyl-phosphocholines. Drugs Future. 19:1021-1037.
3. Houlihan, W.J., M. Lohmeyer, P. Workman, and S.H. Cheon. 1995. Phospholipid antitumor agents. Med. Res. Rev. 15:157-223.
4. Lu, X., and G. Arthur. 1992. Perturbations of cellular acylation processes by the synthetic alkyllysophospholipid 1-O-octadecyl-2-O-methylglycero-3-phosphocholine do not correlate with inhibition of proliferation of MCF-7 and T84 cell lines. Cancer Res. 52:2806-2812.
5. 3 does not correlate with the relative effects of the alkyl-lysophospholipid on the incorporation of fatty acids into cellular phospholipids. Cancer Res. 52:2813-2817.
6. Zhou, X., and G. Arthur. 1995. Effect of 1-O-octadecyl-2-O-methyl-glycero-phosphocholine on phosphatidylcholine and phosphatidylethanolamine synthesis in MCF-7 and A549 cells and its relationship to inhibition of cell proliferation. Eur. J. Biochem. 232:881-888.
7. Boggs, K.P., C.O. Rock, and S. Jackowski. 1995. Lysophosphatidylcholine and 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine inhibit the CDP-choline pathway of phosphatidylcholine synthesis at the CTP:phosphocholine cytidylyltransferase step. J. Biol. Chem. 270:7757-7764.
8. Powis, G. 1991. Signalling targets for anticancer drug development. Trends Pharmacol. Sci. 12:188-194.
9. 2+-dependent protein phosphorylation system in various types of leukemic cell lines HL60 and K562, and its inhibition by alkyl-lysophospholipid. Cancer Res 43:2955-2961.
10. 3 acts as an activator of protein kinase C in HL-60 cells. FEBS Lett. 290:231-234.
11. Salari, H., P. Dryden, R. Davenport, S. Howard, K. Jones, and R. Billman. 1992. Inhibition of protein kinase C by ether-linked lipids is not correlated with their antineoplastic activity on WEH1-3B and R6X-B15 cells. Biochim. Biophys. Acta. 1134:81-88.
12. Berkovic, D., K. Berkovic, E.A. Fleer, H. Eibl, and C. Unger. 1994. Inhibition of calcium-dependent protein kinase C by hexadecylphosphocholine and 1-O-octadecyl-2-O-methyl-rac-glycero-3-phophocholine do not correlate with the inhibition of proliferation of HL60 and K562 cell lines. Eur. J. Cancer. 30A:509-515.
13. 2+ signaling by antitumor ether lipid analogues. Cancer Res. 50:4458-4463.
14. Powis, G., M.J. Seewald, C. Gratas, D. Melder, J. Riebow, and E.J. Modest. 1992. Selective inhibition of phosphatidylinositol phospholipase C by cytotoxic ether lipid analogues. Cancer Res. 52:2835-2840.
15. Berggren, M.I., A. Gallegos, L.A. Dressler, E.J. Modest, and G. Powis. 1993. Inhibition of the signalling enzyme phosphatidylinositol-3-kinase by antitumor ether lipid analogues. Cancer Res. 53:4297-4302.
16. Parker, P.J., and M.D. Waterfield. 1992. Phosphatidylinositol 3-kinase: a novel effector. Cell Growth & Differ. 3:747-752.
17. Marshall, C.J. 1995. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell. 80:179-185.
18. βγ interactions with PH domains and Ras-MAPK signalling pathways. Trends Biochem. Sci. 20:151-156.
19. Ashagbley, A., P. Samadder, R. Bittman, R.K. Erukulla, H.-S. Bynn, and G. Arthur. 1996. Synthesis of ether-linked analogues of lysophosphatidate and their effect on the proliferation of human epithelial cells in vitro. Anticancer Res. In press.
20. Ahn, N.G., J.E. Weiel, C.P. Chan, and E.G. Krebs. 1990. Identification of multiple epidermal growth factor-stimulated protein serine/threonine kinases from Swiss 3T3 cells. J. Biol. Chem. 265:11487-11494.
21. Bogoyevitch, M.A., A. Clerk, and P.H. Sugden. 1995. Activation of the mitogen-activated protein kinase cascade by pertussis toxin-sensitive and -insensitive pathways in cultured ventricular cardiomyocytes. Biochem. J. 309:437-443.
22. Corbin, J.D., and E.M. Reimann. 1974. Assay of cyclic AMP-dependent protein kinases. Methods Enzymol. 38:287-290.
23. Li, B.-Q., D. Kaplan, H. Kung, and T. Kamata. 1992. Nerve growth factor stimulation of the Ras-guanine nucleotide exchange factor and GAP activities. Science (Wash. DC). 256:1456-1459.
24. Wartmann, M., and R.J. Davis. 1994. The native structure of the activated Raf protein kinase is a membrane-bound multi-subunit complex. J. Biol. Chem. 269:6695-6701.
25. Kharbanda, S., A. Saleem, Y. Emoto, R. Stone, U. Rapp, and D. Kufe. 1994. Activation of Raf-1 and mitogen-activated protein kinases during monocytic differentiation of human myeloid leukemia cells. J. Biol. Chem. 269:872-878.
26. Piazza, G.A., J.L. Ritter, and C.A. Baracka. 1995. Lysophosphatidic acid induction of transforming growth factors α and β: modulation of proliferation and differentiation in cultured human keratinocytes and mouse skin. Exp. Cell Res. 216:51-64.
27. Edelmann, H.M.L., C. Kuhne, C. Petritsch and L.M. Ballou. 1996. Cell cycle regulation of p70 S6 kinase and p42/p44 mitogen-activated protein kinases in Swiss mouse 3T3 fibroblasts. J. Biol. Chem. 271:963-971.
28. Anderson, N.G., J.L. Maller, N.K. Tonks, and T.W. Sturgill. 1990. Requirement for integration of signals from two distinct phosphorylation pathways for activation of MAP kinase. Nature (Lond.). 343:651-653.
29. Egan, S.E., B.W. Giddings, M.W. Brooks, L. Buday, A.M. Sizeland, and R.A. Weinberg. 1993. Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation. Nature (Lond.). 363:45-51.
30. Stokoe, D., S.G. Macdonald, K. Cadwallader, M. Symons, and J.F. Hancock. 1994. Activation of raf as a result of recruitment to the plasma membrane. Science (Wash. DC). 264:1463-1467.
31. Leevers, S.J., H.F. Paterson, and C.J. Marshall. 1994. Requirement for ras in raf activation is overcome by targeting raf to the plasma membrane. Nature (Lond.). 369:411-414.
32. Panayotou, G., and M.D. Waterfield. 1993. The assembly of signalling complexes by receptor tyrosine kinases. Bioessays. 15:171-177.
33. Marais, R., Y. Light, H.F. Paterson, and C.J. Marshall. 1995. Ras recruits Raf-1 to the plasma membrane for activation by tyrosine phosphorylation. EMBO J. 14:3136-3145.
34. Cook, S.J., and F. McCormic. 1993. Inhibition of cAMP of ras-dependent activation of raf. Science (Wash. DC). 262:1069-1072.
35. Dent, P., D.B. Reardon, D.K. Morrison, and T.W. Sturgill. 1995. Regulation of Raf-1 and Raf-1 mutants by Ras-dependent and Ras-independent mechanisms in vitro. Mol. Cell. Biol. 15:4125-4135.
36. Cai, H., P. Erhardt, J. Troppmair, M.T. Diaz-Meco, G. Sithanandam, U.R. Rapp, J. Moscat, and G.M. Cooper. 1993. Hydrolysis of phosphatidylcholine couples Ras to activation of Raf protein kinase during mitogenic signal transduclion. Mol. Cell. Biol. 13:7645-7651.
37. Ghosh, S., J.C. Strum, V.A. Sciorra, L. Daniel, and R.M. Bell. 1996. Raf-1 kinase possesses distinct binding domains for phosphatidylserine and phosphatidic acid. J. Biol. Chem. 271:8472-8480.
38. Lowy, D.R., and B.M. Willumsen. 1993. Function and regulation of ras. Annu. Rev. Biochem. 62:851-891.